Hyperfine, Inc. (HYPR)
1.22
+0.01
(+0.83%)
USD |
NASDAQ |
Mar 20, 14:14
Hyperfine Market Cap : 118.55M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pulse Biosciences, Inc. | 1.477B |
| Celldex Therapeutics, Inc. | 2.038B |
| Plus Therapeutics, Inc. | 43.68M |
| Atossa Therapeutics, Inc. | 47.97M |
| Abeona Therapeutics, Inc. | 246.03M |
Market Cap Related Metrics
| PS Ratio | 7.354 |
| Price to Book Value | 2.891 |
| Price | 1.22 |
| Earnings Yield | -36.46% |